{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/trichomoniasis/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"65ddd7d3-15b0-53be-866f-5610e15e070d","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 2563e98b-1106-47d9-a7b1-9dc80e5aebb4 --><h2>Changes</h2><!-- end field 2563e98b-1106-47d9-a7b1-9dc80e5aebb4 -->","summary":null,"htmlStringContent":"<!-- begin item 1f3c278d-920e-44ca-9778-ee78677bf188 --><!-- begin field 5e6bcbeb-2369-4d72-a4dc-d653395eb0ad --><p><strong>May 2020 </strong>— minor update. Tinidazole contraindications and cautions for pregnant women updated in line with manufacturer's SPC.</p><p><strong>November 2019 </strong>— reviewed. A literature search was conducted in October 2019 to identify evidence-based guidelines, UK policy systematic reviews and key randomized controlled trials published since the last review of this topic. No major changes to recommendations have been made.</p><!-- end field 5e6bcbeb-2369-4d72-a4dc-d653395eb0ad --><!-- end item 1f3c278d-920e-44ca-9778-ee78677bf188 -->","topic":{"id":"3fa4323b-9014-5631-9410-a93ec7d2d0ac","topicId":"97ea63d1-8933-4fee-b1dd-7c6ac3ea2ab7","topicName":"Trichomoniasis","slug":"trichomoniasis","lastRevised":"Last revised in May 2020","chapters":[{"id":"e42d9436-b807-5262-a262-948244b520b5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2b56e4dc-02e3-599e-a6bf-1a5413d868f0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"46f9586c-8974-558f-8ac1-6244bfd1883b","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"65ddd7d3-15b0-53be-866f-5610e15e070d","slug":"changes","fullItemName":"Changes"},{"id":"c386cd94-aafd-5fe3-8a55-e502f9f681d1","slug":"update","fullItemName":"Update"}]},{"id":"a7c1505d-66b8-52d6-9b36-239f3eadfed0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c0dae047-42fb-5e25-9862-8967f319e9ee","slug":"goals","fullItemName":"Goals"},{"id":"a4744067-6bed-5f73-8911-66c7ff78570c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"89cbccbf-01cf-5343-bfb7-bad7760a2ded","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8b5c3a47-9564-552f-83c2-64f8926bec29","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6cd42b4c-a956-560f-9c6c-a0e3521bbace","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"9f22fed3-714e-5abe-9a52-34870887e267","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2ebe6cd7-4b6e-5541-9699-5f4e0af542fe","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b4bf3870-e41e-51aa-8ea8-ce962d1735b8","slug":"definition","fullItemName":"Definition"},{"id":"9aec8640-ee39-5d2f-97df-a62f06464af5","slug":"prevalence","fullItemName":"Prevalence"},{"id":"82e41ac8-9c05-5599-bdc6-d1ea0a1ecf7a","slug":"complications","fullItemName":"Complications"}]},{"id":"d1509154-ef5a-52ae-9c75-a9b6bf3bd4bf","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7159a76b-b760-5ee5-8e00-afc991a5ecb9","slug":"diagnosis-women","fullItemName":"Diagnosis - women"},{"id":"159b50a4-88fe-5cf2-9af2-43893eeeec84","slug":"diagnosis-men","fullItemName":"Diagnosis - men"}]},{"id":"004f5906-27c9-56f0-a599-802d0bdffa7c","fullItemName":"Management","slug":"management","subChapters":[{"id":"1c2af37c-700d-5c7c-95ea-049cde93a7e1","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"b06121d3-a41a-5e65-a720-76900da7e5e7","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4c83875e-ed21-58f7-99f4-4a509deb53b5","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"cdff86f4-ac12-56d7-b196-c5f9af1eb880","slug":"tinidazole","fullItemName":"Tinidazole"}]},{"id":"9e19b288-e085-5577-8ad2-b0a504a27f7f","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"7ab5ef58-ff30-5498-8faa-115c4d60dd3f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"11960892-2762-52d0-8fac-3c436e4d4738","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a0cf5333-25ca-5bf8-9b3b-547067cd8d5f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d9ecf639-6f52-5f87-85be-f921ce43f237","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"24dfa3bf-b2cc-5ace-9f72-a47e822dd30a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7c7dfdd9-03c3-520f-a183-13ce32d19151","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c998f4ca-7088-5e78-95d0-67151407d497","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"46f9586c-8974-558f-8ac1-6244bfd1883b","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"77664b16-f184-5902-b531-46bf6f3bae4c","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field e0fb3317-29db-4e40-9309-a8e8d50abc98 --><h3>Previous changes</h3><!-- end field e0fb3317-29db-4e40-9309-a8e8d50abc98 -->","summary":null,"htmlStringContent":"<!-- begin item 34c489bd-4545-46bc-af8d-35bf6adc3a97 --><!-- begin field b8ef10aa-e661-4547-9950-5c393e6c08aa --><p><strong>October 2018 </strong>— minor update. Adverse effects for metronidazole updated within prescribing information. </p><p><strong>January to March 2015 </strong>— reviewed. A literature search was conducted in December 2014 to identify evidence-based guidelines, UK policy systematic reviews and key randomized controlled trials published since the last review of this topic. Advice from the Clinical Effectiveness Group, British Association for Sexual Health and HIV (BASHH)<em>, United Kingdom National Guideline on the Management of Trichomoniasis vaginalis </em>has been added to this topic. No major changes to recommendations have been made.</p><p><strong>August 2009 </strong>— minor update. Advice from the National Institute for Health and Care Excellence (NICE) guideline on when to suspect child maltreatment has been added to this topic. Issued in August 2009.</p><p><strong>February to June 2009 </strong>— converted from CKS guidance to CKS topic structure. The evidence base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to recommendations.</p><p><strong>January 2008 </strong>— minor update. Text changed in line with the National Guideline on the Management of Trichomonas vaginalis (2007) from BASHH. Issued in February 2008.</p><p><strong>October–December 2005 </strong>— reviewed. Validated in March 2006 and issued in May 2006.</p><p><strong>March 2002 </strong>— reviewed. Validated in June 2002 and issued in July 2002.</p><p><strong>June 1999 </strong>— rewritten, replacing previous guidance called <em>Trichomonas vaginalis infection</em>. Validated in October 1999 and issued in January 2000.</p><!-- end field b8ef10aa-e661-4547-9950-5c393e6c08aa --><!-- end item 34c489bd-4545-46bc-af8d-35bf6adc3a97 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}